Kenneth Hung

Kenneth Hung is the Senior Vice President of Clinical Development at Xencor, where they oversee clinical development programs from phase 1 to phase III studies. Previously, Kenneth held various leadership positions at Pfizer, including Director of Precision Medicine and Senior Director in Inflammatory Bowel Disease. Kenneth's extensive experience in clinical research spans several institutions, including Massachusetts General Hospital and Tufts University, where they contributed to both education and clinical care in gastroenterology. Kenneth earned a B.A. in Biochemical Sciences from Harvard University, an M.D., and a Ph.D. in Biochemistry from The Johns Hopkins University.